INTEGRATED CORE STRATEGIES (US) LLC

13D and 13G Filings

13D/G filings
13G on 78 securities
CIK
0001319244
All SEC filings
View on sec.gov
Issuer % of Class Filed
Sealed Air Corporation 13G
SEE · 81211K100
5.1% 11/7/2025
Event 11/3/2025
LivaNova PLC 13G/A Amendment 2
LIVN · G5509L101
5.4% 11/6/2025
Event 9/30/2025
Tenax Therapeutics, Inc. 13G/A Amendment 1
TENX · 88032L605
6.9% 11/5/2025
Event 9/30/2025
OrthoPediatrics Corp. 13G
KIDS · 68752L100
5.5% 11/4/2025
Event 10/29/2025
Cumberland Pharmaceuticals Inc. 13G/A Amendment 2
CPIX · 230770109
4.0% 10/30/2025
Event 9/30/2025
Affiliated Managers Group, Inc. 13G/A Amendment 1
AMG · 008252108
3.6% 10/30/2025
Event 9/30/2025
Harvard Ave Acquisition Corporation 13G
HAVAU · G4330A129
6.4% 10/29/2025
Event 10/23/2025
Nektar Therapeutics 13G/A Amendment 1
NKTR · 640268306
3.0% 10/28/2025
Event 9/30/2025
Quoin Pharmaceuticals Ltd. 13G
QNRX · 74907L409
9.0% 10/27/2025
Event 10/20/2025
First Horizon Corporation 13G
FHN · 320517105
5.0% 10/23/2025
Event 10/16/2025
Astria Therapeutics, Inc. 13G/A Amendment 1
ATXS · 04635X102
0.4% 10/20/2025
Event 10/14/2025
Comerica Incorporated 13G/A Amendment 1
CMA · 200340107
3.6% 10/9/2025
Event 10/7/2025
BioXcel Therapeutics, Inc. 13G
BTAIQ · 09075P204
5.2% 10/1/2025
Event 9/29/2025
Cryoport, Inc. 13G
CYRX · 229050307
5.1% 9/26/2025
Event 9/24/2025
Lexeo Therapeutics, Inc. 13G/A Amendment 1
LXEO · 52886X107
5.3% 8/7/2025
Event 6/30/2025
Cryoport, Inc. 13G/A Amendment 2
CYRX · 229050307
4.4% 8/5/2025
Event 6/30/2025
Myriad Genetics, Inc. 13G/A Amendment 1
MYGN · 62855J104
5.3% 8/4/2025
Event 6/30/2025
UWM Holdings Corporation 13G/A Amendment 2
UWMC · 91823B109
2.5% 8/1/2025
Event 6/30/2025
Helix Acquisition Corp. II 13G/A Amendment 1
HLXB · G4444H101
4.7% 7/30/2025
Event 6/30/2025
Comerica Incorporated 13G
CMA · 200340107
6.6% 7/23/2025
Event 7/16/2025
AngioDynamics, Inc. 13G
ANGO · 03475V101
5.3% 7/22/2025
Event 7/16/2025
NeoGenomics, Inc. 13G/A Amendment 1
NEO · 64049M209
2.8% 7/17/2025
Event 6/30/2025
Nektar Therapeutics 13G
NKTR · 640268306
5.4% 7/3/2025
Event 6/27/2025
Tenax Therapeutics, Inc. 13G
TENX · 88032L605
5.6% 6/30/2025
Event 6/26/2025
Astria Therapeutics, Inc. 13G
ATXS · 04635X102
5.2% 6/18/2025
Event 6/13/2025
Affiliated Managers Group, Inc. 13G
AMG · 008252108
5.3% 6/6/2025
Event 6/2/2025
ANI Pharmaceuticals, Inc. 13G
ANIP · 00182C103
5.2% 6/4/2025
Event 5/30/2025
Utz Brands, Inc. 13G
UTZ · 918090101
5.3% 5/28/2025
Event 5/23/2025
Affiliated Managers Group, Inc. 13G
AMG · 008252108
4.3% 5/14/2025
Event 5/7/2025
LivaNova PLC 13G/A Amendment 1
LIVN · G5509L101
3.8% 5/13/2025
Event 3/31/2025
UWM Holdings Corporation 13G/A Amendment 1
UWMC · 91823B109
6.3% 5/12/2025
Event 3/31/2025
COMPASS Pathways plc 13G/A Amendment 2
CMPS · 20451W101
3.0% 5/7/2025
Event 3/31/2025
Pyxis Oncology, Inc. 13G/A Amendment 1
PYXS · 747324101
4.0% 5/6/2025
Event 3/31/2025
Golar LNG Limited 13G/A Amendment 1
GLNG · G9456A100
0.1% 5/2/2025
Event 3/31/2025
Abeona Therapeutics Inc. 13G/A Amendment 3
ABEO · 00289Y206
1.7% 5/1/2025
Event 3/31/2025
Milestone Pharmaceuticals Inc. 13G/A Amendment 4
MIST · 59935V107
0.6% 4/30/2025
Event 3/31/2025
Lexeo Therapeutics, Inc. 13G
LXEO · 52886X107
5.8% 4/28/2025
Event 4/22/2025
PHINIA Inc. 13G/A Amendment 1
PHIN · 71880K101
0.5% 4/25/2025
Event 3/31/2025
Cumberland Pharmaceuticals Inc. 13G/A Amendment 1
CPIX · 230770109
5.8% 4/24/2025
Event 3/31/2025
Granite Construction Incorporated 13G/A Amendment 1
GVA · 387328107
3.0% 4/22/2025
Event 3/31/2025
NeoGenomics, Inc. 13G
NEO · 64049M209
5.4% 3/18/2025
Event 3/13/2025
Golar LNG Limited 13G
GLNG · G9456A100
5.3% 2/28/2025
Event 2/25/2025
UWM Holdings Corporation 13G
UWMC · 91823B109
6.7% 2/11/2025
Event 2/6/2025
Cumberland Pharmaceuticals Inc. 13G
CPIX · 230770109
8.8% 2/11/2025
Event 2/5/2025
Acelyrin, Inc. 13G/A Amendment 1
SLRN · 00445A100
4.7% 2/10/2025
Event 12/31/2024
COMPASS Pathways plc 13G/A Amendment 1
CMPS · 20451W101
3.7% 2/6/2025
Event 12/31/2024
Accolade, Inc. 13G/A Amendment 1
ACCD · 00437E102
3.8% 1/30/2025
Event 12/31/2024
Astria Therapeutics, Inc. 13G/A Amendment 1
ATXS · 04635X102
3.5% 1/28/2025
Event 12/31/2024
Adaptive Biotechnologies Corporation 13G/A Amendment 2
ADPT · 00650F109
4.3% 1/27/2025
Event 12/31/2024
Enanta Pharmaceuticals, Inc. 13G
ENTA · 29251M106
6.5% 1/22/2025
Event 1/14/2025
Pyxis Oncology, Inc. 13G
PYXS · 747324101
5.3% 12/16/2024
Event 12/9/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.